This question has been answered by the relevant Government Department.
Lord Dubs to ask Her Majesty's Government what assessment they have made of (1) advances in treatments for multiple sclerosis for NHS patients, including the recently approved first short course oral treatment, cladribine tablets; and (2) the extent to which new treatments will help to reduce burdens on NHS services. HL2994
Legend for business item text
† Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.